Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 20, 2024Vercise™ Neural Navigator 5 con tecnologia STIMVIEW™ XT è progettato per semplificare la procedura per le persone affette da patologie neurologiche.
HEMEL HEMPSTEAD, Regno Unito – Giovedì 20 giugno 2024 – Boston Scientific Corporation (NYSE: BSX) ha ottenuto il marchio CE per il software Vercise™ Neural Navigator 5 con tecnologia...
-
Jun 20, 2024Vercise™ Neural Navigator 5 con tecnología STIMVIEW™ XT está diseñado para agilizar el procedimiento para las personas que viven con afecciones neurológicas
Madrid, 20 de junio de 2024 – Boston Scientific Corporation (NYSE: BSX) ha obtenido la aprobación del marcado CE para su Software Vercise™ Neural Navigator 5 con tecnología STIMVIEW™ XT....
-
Jun 20, 2024Vercise™ Neural Navigator 5 mit STIMVIEW™ XT-Technologie soll das Verfahren für Menschen mit neurologischen Störungen vereinfachen
DÜSSELDORF – 20. Juni 2024 – Die Boston Scientific Corporation (NYSE: BSX) hat die CE-Kennzeichnung für die Vercise™ Neural Navigator 5 Software mit STIMVIEW™ XT Technologie erhalten,...
-
Jun 20, 2024Vercise™ Neural Navigator 5 with STIMVIEW™ XT technology is designed to streamline procedure for people living with neurological conditions
HEMEL HEMPSTEAD, United Kingdom – 20 June 2024 – Boston Scientific Corporation (NYSE: BSX) has obtained CE Mark on the Vercise™ Neural Navigator 5 Software with STIMVIEW™ XT technology,...
-
Jan 8, 2024Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a publicly traded medical technology company primarily...